Combined Therapeutics Patents – Insights & Stats (Updated 2024)
Combined Therapeutics has a total of 48 patents globally, out of which 7 have been granted. Of these 48 patents, more than 83% patents are active. Europe (EPO) is where…
Combined Therapeutics has a total of 48 patents globally, out of which 7 have been granted. Of these 48 patents, more than 83% patents are active. Europe (EPO) is where…
Phanes Therapeutics has a total of 246 patents globally, out of which 23 have been granted. Of these 246 patents, more than 83% patents are active. China and Europe (EPO)…
Khloris Biosciences has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. United States of…
Kelonia Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States…
Cambridge Technologies has a total of 9 patents globally, out of which 4 have been granted. Of these 9 patents, more than 88% patents are active. Mexico, The United States…
Capsida Biotherapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 65% patents are active. Australia and Canada…
Spirovant Sciences has a total of 37 patents globally, out of which no patents have been granted. Of these 37 patents, more than 89% patents are active. Parallelly, United States…
Tevogen Bio has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 80% patents are active. United States of America…
Acceligen has a total of 9 patents globally. Of these 9 patents, more than 66% patents are active. United States of America and Australia are where Acceligen has filed the…
Vytelle has a total of 38 patents globally, out of which 14 have been granted. Of these 38 patents, more than 73% patents are active. Australia and Canada is where…
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.